PT Kalbe Farma Tbk. (IDX:KLBF)

Revenue by Segment

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Prescription Pharmaceutical	10.24T	9.23T	8.22T	6.15T	5.72T
Prescription Pharmaceutical Growth	11.01%	12.21%	33.71%	7.50%	14.76%
Consumer Health	4.83T	4.31T	4.05T	4.15T	3.62T
Consumer Health Growth	11.90%	6.52%	-2.50%	14.63%	7.11%
Nutritionals	8.05T	8.19T	8.37T	7.83T	7.17T
Nutritionals Growth	-1.73%	-2.19%	6.91%	9.27%	2.47%
Distribution and Logistic	12.21T	10.90T	9.81T	10.80T	9.75T
Distribution and Logistic Growth	12.02%	11.15%	-9.21%	10.76%	25.80%
Total	35.32T	32.63T	30.45T	28.93T	26.26T
Total Growth	8.27%	7.16%	5.24%	10.18%	13.62%

Revenue by Geography

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Indonesia	32.70T	30.82T	28.56T	27.24T	25.01T
Indonesia Growth	6.10%	7.93%	4.84%	8.91%	13.70%
Exports	2.62T	1.80T	1.89T	1.69T	1.25T
Exports Growth	45.30%	-4.50%	11.74%	35.50%	12.17%
Total	35.32T	32.63T	30.45T	28.93T	26.26T
Total Growth	8.27%	7.16%	5.24%	10.18%	13.62%

Source: S&P Global Market Intelligence.